Annex Publishers | Open Access Journals

Latest Articles

JCRS

ECHOES-OF-AGING-A-CLINICAL-INSIGHT-INTO-PRESBYPHONIA-AND-PRESBYPHAGIA-A CLINICAL-CASE-TRIAL

ROY DR REENY — Journal of Case Reports and Studies

Age related changes in combination of voice and swallowing are often unaddressed in geriatric population. The study highlights the coexistence of presbyphonia and presbyphagia. Early diagnosis and providing appropriate intervention strategies can help improve the individual’s quality of life.

PDF

JCS

Trastuzumab-Deruxtecan-and-Pertuzumab-inp-HER2-Positive-Advanced-Breast-Cancer

Aliza Aamir Akhss-Karimabad — Journal of Cancer Science and Clinical Oncology

The results of the HER2-Positive Advanced Breast Cancer trial presented by Dr. Sara M. Tolaney at the ASCO Annual Meeting 2025, shows a promising new treatment for metastatic HER2-positive breast cancer. The study found that using T-DXd with pertuzumab nearly doubles how long patients can control their disease compared to the standard treatment, THP.1.

PDF

JCERC

Fish-Oil-Supplementation-and-Cardiovascular-Events-in-Patients

Aliza Aamir Akhss-Karimabad — Clinical and Experimental Research in Cardiology

The results highlight the notetaking findings from the PISCES trial conducted by Dr. Charmaine E. Lok, who studied the impact of fish-oil supplementation on cardiovascular diseases among the haemodialysis patients. Between November 28, 2013, and July 22, 2019, 1,228 participants were under randomized case-study, with 610 assigned to the fish-oil group and 618 to the placebo group [1]. Over a follow-up period of 3.5 years, results showed a noticeable lower rate of serious cardiovascular diseases in the fish-oil group (0.31 vs. 0.61 per 1000 patient days), providing a hazard ratio of 0.57 (95% CI, 0.47 to 0.70; P<0.001) [2].

PDF

JAHI

HIV-Associated Intracranial Aneurysmal Vasculopathy in Adults: A Rare but De- vastating Neurological Complication

Kamalesh Tayade*, Anarya Karle, Haresh Bharote, Dnyaneshwar Asole, Anil Venkitachalam, Amarnath Cha- van and Jivan Morey — Journal of AIDS and HIV Infections

HIV-associated intracranial aneurysmal vasculopathy is a rare, poorly understood, and almost invariably catas- trophic complication of advanced immunosuppression. It’s defining feature — multiple fusiform aneurysms erupting along the walls of cerebral arteries — reflects a convergence of viral endothelial injury, chronic inflammation, and opportunistic patho- gen invasion that together dismantle the structural integrity of the cerebrovascular tree.

PDF

JOO

Survodutide for Treatment of Obesity: Baseline Characteristics, what This Trial Analyzes, and What Its Limitations Are

Ahmed Jumani — Journal of Obesity and Overweight

In the SYNCHRONIZE-1 trial conducted by Le Roux CW, the efficacy and safety of Survodutide for the treatment of obesity were analyzed in patients aged 18 or older with a BMI of 30 or above (meaning obese); patients with a BMI of 27 or above with at least one overweight-related health issue like hypertension, etc.; and patients having a history of unsuccessful dietary weight loss.

Full Text PDF

JAR

Drug Utilization and Evaluation of Antibiotics in Pre & Post-Operative Obstetrics Ward at a Tertiary Care Hospital

Dr. Narendra Bheemraj Parihar — Journal of Antibiotics Research

Antibiotics are especially used in obstetric practice during c-section as there is greater chance of postoperative infection.

Full Text PDF

View All Articles →

Announcements

Call for Papers

Special Issue: AI in Drug Discovery & Development

We invite original research and review articles exploring artificial intelligence and machine learning applications in pharmaceutical sciences.

Deadline: 2026-06-30

News

Annex Publishers Journals Now Indexed in Portico

All Annex Publishers journals are now preserved in Portico, ensuring long-term digital preservation of published research.

2026-03-15

Special Issue

Advances in Nanomedicine: From Bench to Bedside

Guest-edited collection featuring cutting-edge research on nanoparticle drug delivery, diagnostics, and theranostics.

Submissions Open

Why Publish With Us

Rapid Peer Review

Average first decision within 21 days through our efficient editorial workflow and dedicated reviewer network.

Immediate Open Access

All articles freely available upon publication under CC BY 4.0 license, maximizing research visibility and impact.

Global Indexing

Content indexed in PubMed, Google Scholar, CrossRef, and 20+ international databases for maximum discoverability.

Dedicated Support

Personal editorial assistance from submission through publication with responsive author support services.

About Annex Publishers

Annex Publishers is an international open access publisher dedicated to disseminating high-quality research across the scientific, technical, and medical disciplines. We operate over 82 peer-reviewed journals covering life sciences, medicine, engineering, environmental science, and more.